Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
PLN 0.58
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, hematology, veterinary, urinalysis, and parasitology, as well as rapid test products. The company serves small and medium size clinical laboratories, clinics, and hospitals. It distributes its products to approximately 120 countries. PZ Cormay S.A. was founded in 1985 and is headquartered in Lomianki, Poland.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is neutral on EV/EBITDA.
Data is available to registered users only
